ApprovalTrail

Approval · Notice of Compliance 6745 · 1998

FACTREL INJECTION: Notice of Compliance 6745

Issued May 15, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6745
Date
May 15, 1998
Company
Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Synthetic luteinizing hormone-releasing hormone

Products in this notice

BrandDINStatus today
FACTREL INJECTION00573760Marketed

Medicinal ingredients